B

Brendan D. Manning

Cancer Research Center

ORCID: 0000-0003-3895-5956

Publishes on PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, RNA modifications and cancer. 224 papers and 42.5k citations.

PubIndex Score98Top 2%How it's scored

🌟#9 Current Senior Leader in Tuberous Sclerosis Complex Research

224Publications

42.5kTotal Citations

#9in Tuberous Sclerosis Complex Research

First publication: 1992First senior author: 2006

PI3K/AKT/mTOR signaling in cancer Lung Cancer Treatments and Mutations RNA modifications and cancer Tuberous Sclerosis Complex Research Cancer, Hypoxia, and Metabolism

Top publicationsby citations

Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway

Huihui Zhang, Brendan D. Manning|PLoS ONE|2009

Cited by 395

The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals

Margaret E. Torrence, Brendan D. Manning, Michael R. MacArthur et al.|eLife|2021

Cited by 246

Nutrient Sensing in Cancer

Margaret E. Torrence, Brendan D. Manning|Annual Review of Cancer Biology|2017

Cited by 56

mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid species

Aaron M. Hosios, Brendan D. Manning, Molly C. McNamara et al.|Nature Metabolism|2022

Cited by 53

IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex

Alexander J. Valvezan, Brendan D. Manning, Molly C. McNamara et al.|JCI Insight|2020

Cited by 38